These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12382364)
1. [Positron emission tomography in the Netherlands: need to expand the capacity]. Comans EF; Smit EF Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1817-9. PubMed ID: 12382364 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA; Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081 [TBL] [Abstract][Full Text] [Related]
3. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Reske SN; Kotzerke J Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115 [TBL] [Abstract][Full Text] [Related]
4. Staging of non-small-cell lung cancer and application of FDG-PET. A cost modeling approach. Verboom P; Herder GJ; Hoekstra OS; Smit EF; van den Bergh JH; van Velthoven PC; Grijseels EW Int J Technol Assess Health Care; 2002; 18(3):576-85. PubMed ID: 12391950 [TBL] [Abstract][Full Text] [Related]
5. [Cost-effective PET scans in oncology]. Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909 [TBL] [Abstract][Full Text] [Related]
6. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer]. Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692 [TBL] [Abstract][Full Text] [Related]
7. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902 [TBL] [Abstract][Full Text] [Related]
8. [Cost-effective PET investigations in oncology]. Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917 [TBL] [Abstract][Full Text] [Related]
9. Role of FDG-PET in the diagnosis and management of lung cancer. Oyen WJ; Bussink J; Verhagen AF; Corstens FH; Bootsma GP Expert Rev Anticancer Ther; 2004 Aug; 4(4):561-7. PubMed ID: 15270660 [TBL] [Abstract][Full Text] [Related]
10. 18-Fluorodeoxyglucose imaging in oncology. Harolds JA J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797 [TBL] [Abstract][Full Text] [Related]
12. Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals. Herder GJ; Verboom P; Smit EF; van Velthoven PC; van den Bergh JH; Colder CD; van Mansom I; van Mourik JC; Postmus PE; Teule GJ; Hoekstra OS Thorax; 2002 Jan; 57(1):11-4. PubMed ID: 11809983 [TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography imaging in evaluation of cancer patients. Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112 [TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of FDG-PET in oncology]. Sasaki M Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817 [TBL] [Abstract][Full Text] [Related]
15. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose. Giorgetti A; Volterrani D; Mariani G Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381 [TBL] [Abstract][Full Text] [Related]
16. A review of the literature for whole-body FDG PET in the management of patients with melanoma. Schwimmer J; Essner R; Patel A; Jahan SA; Shepherd JE; Park K; Phelps ME; Czernin J; Gambhir SS Q J Nucl Med; 2000 Jun; 44(2):153-67. PubMed ID: 10967625 [TBL] [Abstract][Full Text] [Related]
17. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy. Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner. Hicks RJ; Binns DS; Fawcett ME; Ware RE; Kalff V; McKenzie AF; Zalcberg JP; Peters LJ Med J Aust; 1999 Nov; 171(10):529-32. PubMed ID: 10816703 [TBL] [Abstract][Full Text] [Related]
19. [18F FDG PET- applications in oncology]. Răileanu I; Rusu V; Stefănescu C; Cinotti L Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):638-45. PubMed ID: 12092212 [TBL] [Abstract][Full Text] [Related]
20. Value of positron emission tomography for lung cancer staging. Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]